Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
News|Articles|March 30, 2020
- Pharmaceutical Technology's In the Lab eNewsletter-04-01-2020
- Volume 15
- Issue 4
trinamiX Launches a Mobile NIR Spectroscopy Solution
The measurement device comes with an infrared semiconductor to examine the molecular structure of materials in a wavelength range up to 2,5 µm for factory and lab applications.
Advertisement
trinamiX GmbH, a subsidiary of BASF SE, announced on March 23, 2020 that it is launching a mobile, handheld near-infrared (NIR) spectroscopy solution for factory and laboratory applications.
The measurement device comes equipped with an infrared semiconductor to efficiently examine the molecular structure of materials in a wavelength range up to 2,5 µm, along with mobile and robust hardware, precise data and material analytics, and molecular and chemical capabilities.
Device capabilities include inbound control, quality checks, on-the-field analytics, and material sorting and identification. The company states that trinamiX production capabilities are suited for high-volume production that runs all the way up to consumer electronics-level supply demands.
Source:
Articles in this issue
over 6 years ago
Asymmetrex’s New Algorithms Offer Low Cost Rapid Cell Countingover 6 years ago
Integra Now Offers New High-Volume Pipettesover 6 years ago
Trianni in License Agreement with Nkarta for Trianni Mouseover 6 years ago
Thermo Fisher Scientific to Acquire Qiagen for $11.5 BillionAdvertisement
Related to this article
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Risk-Based Life Cycle Management of Master Production and Control Records to Strengthen Data Integrity and GMP Inspection Readiness Part 2: Practical Considerations for CGMP Documentation Systems
2
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
3
PharmTech’s Weekly Roundup—September 25, 2026
4
CPHI Milan: USP Benchmarks Reshape Procurement Incentives
5